Crowdonomics
All companies
InnaMed (YC W17) logo

InnaMed (YC W17)

Operating

InnaMed, Inc.

Biotech · Philadelphia, PA · Founded 2016

Minority-founded
Visit website

Using at-home blood testing technology to enable personalized medicine

Valuation cap ⓘ
$25.0M
As of May 2021 · from INNAMED SAFE 2 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$2,350,506
Across 2 rounds since 2019

Financials

FY2017–FY2021 · from SEC filings · hover any figure for its source
$0
−$424K
2017
$237K
−$475K
2018
$40K
−$414K
2019
$207K
−$282K
2020
$1.4M
−$2.0M
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2017
FY2018
FY2019
FY2020
FY2021
Income statement
Revenue
$0
$237,435
$40,000
$207,418
$1,439,995
Cost of goods sold
$0
$0
$0
$0
$0
Gross margin
—
100%
100%
100%
100%
Net income
-$424,383
-$474,753
-$414,407
-$282,354
-$1,951,729
Taxes paid
$0
$808
$0
$1,638
$4,024
Balance sheet
Cash
$393,754
$844,551
$80,049
$572,704
$1,051,262
Accounts receivable
$0
$0
$0
$150,000
$0
Total assets
$438,294
$882,560
$124,271
$819,936
$1,144,743
Short-term debt
$0
$3,426
$384
$196,705
$88
Long-term debt
$0
$0
$0
$30,000
$45,229
Total liabilities
$0
$3,426
$384
$226,705
$45,317
Other
Headcount
—
3
7
7
14

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$12.0M
Valuation cap
$25.0M
Valuation cap
INNAMED Crowd SAFE 1
INNAMED SAFE 2

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

INNAMED SAFE 2ClosedReg CF · SAFE · via WeFunder
Raised $1.3M / $1.1MInvestors 1,407Valuation cap $25M
INNAMED Crowd SAFE 1ClosedReg CF · SAFE · via Republic
Raised $1.1M / $1.1MInvestors 2,440Valuation cap $12M

Team

2 people
Eshwar Inapuri
CEO
Anup Singh
CSO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 2 of 7 annual reports (FY2019–FY2025)

2,440 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARApr 28, 20220001773255-22-000005
    EDGAR
  • Form C-TRApr 28, 20220001773255-22-000006
    EDGAR
  • Form C/AApr 1, 20210001670254-21-000409
    EDGAR
  • Form CFeb 19, 20210001670254-21-000178
    EDGAR
  • Form C-TRApr 23, 20200001773255-20-000003
    EDGAR
  • Form C-ARApr 23, 20200001773255-20-000001
    EDGAR
  • Form C-UAug 1, 20190001773255-19-000002
    EDGAR
  • Form CApr 30, 20190001773255-19-000001
    EDGAR
Source: ManualCIK 0001773255DE

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.